PMI index climbs in December

PMIPurchasing Managers Index rose by 2.6 percentage points during the month of December compared with the previous month on the back strong demand for Israeli products in Israel and abroad, D&B Israel reported.

By SHARON WROBEL
January 17, 2007 07:32

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Israel Purchasing Managers Index rose by 2.6 percentage points during the month of December compared with the previous month on the back strong demand for Israeli products in Israel and abroad, Dun & Bradstreet Israel reported on Tuesday. Economists at D&B Israel who compile the index attributed the increase in its value from 53.3% in November to 55.9% in December to the significant boost in production levels, which rose from 57.8% to 64.9% during the same period. At the same time demand for exports grew from 53.1% to 55.5%, while domestic demand was also up from 53.5% to 55.7%. In addition, the report showed that the employment component of the index fell from 66.3% to 60.9%.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS